Ontario, Calif., January 3rd, 2023 — Kiwa Bio-Tech Products Group Corporation (“Kiwa” or the “Company”) (PINK: KWBT). On January 3rd, 2023, The Board of Directors (the “Board”) of Kiwa Bio-Tech Products Group Corporation (the “Company”) is pleased to announce appointment of new directors.
The following persons are elected to the positions indicated next to their names to serve until their successors shall be duly elected, unless he or she resigns, is removed from office or is otherwise disqualified from serving as an office or director of the Company, to take their respective offices immediately upon such appointment:
| Position | Name |
| Director | Changyi Hu |
| Director | Hao Pang |
| Director | Shouming Zheng |
| Director | Dan Liu |
| Director | Yun Zhang |
| Chairman and CEO | Ziqi Wang |
| Chief Operating Officer | Boyu Liu |
| Executive President and General Manager of Mining Business Department | Chaozhao Zhao |
| Executive Vice President | Dadong Li |
| Chief Financial Officer | Sen yang |
| CAO and CGO | Mingzheng Bao |
Forward-Looking Statements
This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more fully disclosed in the Company’s reports filed with the U.S. Securities and Exchange Commission. The forward-looking information provided herein represents the Company’s estimates as of the date of the press release, and subsequent events and developments may cause the Company’s estimates to change. The Company’s actual results may differ materially from those anticipated in the forward-looking statements depending on a number of risk factors including, but not limited to, the following: general economic, business and environment conditions, development, shipment, market acceptance, additional competition from existing and new competitors, changes in technology, the execution of its ten-year growth plan, the foreign exchange risk amid the unexpected announcements by the PRC government and various other factors beyond the Company’s control. Kiwa Bio-Tech Products Group Corp. specifically disclaims any obligation to update the forward-looking information in the future. Therefore, this forward-looking information should not be relied upon as representing the Company’s estimates of its future financial performance as of any date subsequent to the date of this press release.
For investor and media inquiries, please contact:
Email: myli@kiwabiotech.com
